Regenerex Pharma (RGPX) Other Gross PP&E Adjustments (2022 - 2025)

Regenerex Pharma (RGPX) has 4 years of Other Gross PP&E Adjustments data on file, last reported at -$565707.0 in Q3 2025.

• Other Gross PP&E Adjustments for Q3 2025 came in at -$565707.0, up 9.59% year-over-year; the trailing twelve-month figure through Sep 2025 was -$565707.0 (up 9.59% YoY), and the FY2025 annual result was -$609861.0, up 20.01% from the prior year.
• Other Gross PP&E Adjustments held at -$565707.0 in Q3 2025 per RGPX's latest filing, from -$566353.0 in the prior quarter.
• Over five years, Other Gross PP&E Adjustments peaked at -$1201.0 in Q1 2023 and troughed at -$945062.0 in Q2 2023.
• A 4-year average of -$600081.5 and a median of -$635775.5 in 2024 frame the typical range for Other Gross PP&E Adjustments.
• The sharpest annual moves came in 2023 and 2024: Other Gross PP&E Adjustments sank 63792.1% in 2023, then surged 31.29% in 2024.
• A 4-year view of Other Gross PP&E Adjustments shows it stood at -$1316.0 in 2022, then slumped by 63792.1% to -$840820.0 in 2023, then grew by 23.19% to -$645872.0 in 2024, then advanced by 12.41% to -$565707.0 in 2025.
• Business Quant data shows RGPX's Other Gross PP&E Adjustments at -$565707.0 in Q3 2025, -$566353.0 in Q2 2025, and -$609861.0 in Q1 2025.